In the context of cancer, the cGAS-STING signaling exhibits a dual nature, exerting anti-tumor effects through the induction of IFNs while, paradoxically, fostering tumor progression in certain scenarios via the promotion of chronic inflammation (14, 27). Here, STING1 is linked to cancer.